An experimental therapeutic vaccine did not slow CD4 T-cell decline or enable study participants to safely interrupt antiretroviral therapy longer, but it did appear to leave HIV viral load at lower levels, researchers reported in the February 11 advance edition of Lancet Infectious Diseases .
http://ift.tt/1mwt0gC
http://ift.tt/1mwt0gC
No comments:
Post a Comment